TWC
SKYE icon

TD Waterhouse Canada’s Skye Bioscience SKYE Stock Holding History

TD Waterhouse Canada’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35 Sell
7
-3
-30% -$19 ﹤0.01% 2359
2026
Q1 		$51 Buy
10
+7
+233% +$46 ﹤0.01% 2254
2025
Q4 		$18 Hold
3
– – ﹤0.01% 2017
2025
Q3 		$107 Hold
3
– – ﹤0.01% 1992
2025
Q2 		$93 Hold
3
– – ﹤0.01% 1916
2025
Q1 		$35 Hold
3
– – ﹤0.01% 1898
2024
Q4 		$71 Buy
+3
New +$100 ﹤0.01% 1902
2024
Q3 		– Hold
0
– – – 1886
2024
Q2 		– Hold
0
– – – 1893

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TD Waterhouse Canada's SKYE Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Skye Bioscience (SKYE) stake by 30% in Q2 2026, selling an estimated $19 and leaving 7 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

TD Waterhouse Canada first reported a position in SKYE in Q4 2024 and has held it in 7 quarters since. The position peaked at $107 in Q3 2025. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • TD Waterhouse Canada held 7 shares of Skye Bioscience worth $35 as of Q2 2026.
  • TD Waterhouse Canada sold 3 Skye Bioscience shares in Q2 2026, an estimated $19.
  • Skye Bioscience made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2359 holding.
  • TD Waterhouse Canada first reported a position in Skye Bioscience in Q4 2024 and has held it in 7 quarters since.
  • TD Waterhouse Canada's Skye Bioscience position peaked at $107 in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.